January 3, 2010
|
Journal Article
This article explores both national and regional trends in rates of Acinetobacter resistance to imipenem, an antibiotic often reserved as a last-line treatment for infections.
November 18, 2010
|
Story
RWJF-funded program is partnering with the CDC in a new campaign to raise awareness.
September 7, 2010
|
News Release
Proposal would reward drug companies for reducing resistance.
February 22, 1010
|
Journal Article
A new study, based on national hospital discharge data, finds the clinical and economic costs of sepsis and pneumonia infections contracted while in the hospital are substantial and vary among patient groups. Commentary estimates that in 2006, 48,000 people died from these infections and there were $8.1 billion associated hospital costs.
February 26, 2009
|
Commentary/Story
Some 5 percent of patients admitted to a U.S. hospital will contract an infection during their stay. Such infections cause a staggering 99,000 deaths per year, and a growing proportion no longer respond to a wide range of antibiotics. The RWJF-funded Extending the Cure project has published three op-ed articles recently on this critical topic.
February 21, 2010
|
News Release/Video
Hospital-acquired infections (HAIs) killed 48,000 people and ramped up health care costs by $8.1 billion in 2006 alone.
November 23, 2009
|
News Release
Seven-fold Increase in Potentially Lethal Superbug
June 1, 2004
|
Journal Article
Since about 1996, doctors have routinely prescribed antibiotics such as ampicillin for pregnant women to prevent their newborns from getting group B streptococcal infections. Some recent studies suggest that low-birth-weight infants now develop othe ...
November 1, 2006
|
Journal Article
Since the 1960s, scientists and pharmaceutical representatives have called for the advancement and development of new antimicrobial drugs to combat infectious diseases. In January 2005, Senate Majority Leader Bill Frist (R-TN), M.D., introduced a bi ...
March 20, 2009
|
News Release/Video
"Positive deviance" efforts turn the tide on antibiotic-resistant infections.